 LEIDEN, Netherlands CAMBRIDGE, Mass., April 02, 2021 GLOBE NEWSWIRE -- ProQR Therapeutics N.V. Nasdaq:PRQR, a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual presentation at the Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus AAPOS held April 9-11, 2021. 